Why the study?
Mobile health apps may help improve lifestyles and prevent cardiovascular disease, but few have undergone large, well-designed epidemiological research.
Does the use of the kencom mHealth app improve physical activity levels and cardiovascular risk biomarkers in a generally healthy population?
Does the use of the kencom mHealth app improve physical activity levels and cardiovascular risk biomarkers in a generally healthy population?
The use of a lifestyle mHealth app was associated with a significant increase in daily step count and modest improvements in cardiovascular risk biomarkers such as weight and lipid profile.
Answers are grounded in this paper and cite their sources.
App use was associated with higher step counts and modest risk-factor shifts; hypothesis-generating for mHealth in CVD prevention, needing RCTs before adoption.
BACKGROUND Mobile health (mHealth) apps are considered to be potentially powerful tools for improving lifestyles and preventing cardiovascular disease (CVD), although only few have undergone large, well-designed epidemiological research. “kencom” is a novel mHealth app with integrated functions for healthy lifestyles such as monitoring daily health/step data, providing tailored health information, or facilitating physical activity through group-based game events. The app is linked to large-scale Japanese insurance claims databases and annual health check-up databases, thus comprising a large longitudinal cohort. OBJECTIVE We aimed to assess the effects of kencom on physical activity levels and CVD risk factors such as obesity, hypertension, dyslipidemia, and diabetes mellitus in a large population in Japan. METHODS Daily step count, annual health check-up data, and insurance claim data of the kencom users were integrated within the kencom system. Step analysis was conducted by comparing the 1-year average daily step count before and after kencom registration. In the CVD risk analysis, changes in CVD biomarkers following kencom registration were evaluated among the users grouped into the quintile according to their change in step count. RESULTS A total of 12,602 kencom users were included for the step analysis and 5473 for the CVD risk analysis. The participants were generally healthy and their mean age was 44.1 (SD 10.2) years. The daily step count significantly increased following kencom registration by a mean of 510 steps/day (P<.001). In particular, participation in “Arukatsu” events held twice a year within the app was associated with a remarkable increase in step counts. In the CVD risk analysis, the users of the highest quintile in daily step change had, compared with those of the lowest quartile, a significant reduction in weight (–0.92 kg, P<.001), low-density lipoprotein cholesterol (–2.78 mg/dL, P=.004), hemoglobin A1c (HbA1c; –0.04%, P=.004), and increase in high-density lipoprotein cholesterol (+1.91 mg/dL, P<.001) after adjustment of confounders. CONCLUSIONS The framework of kencom successfully integrated the Japanese health data from multiple data sources to generate a large, longitudinal data set. The use of the kencom app was significantly associated with enhanced physical activity, which might lead to weight loss and improvement in lipid profile.
No takes yet. Share an insight, caveat, or question.
Hamaya et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: